Neuland Laboratories Limited Share Price NSE India S.E.
Stocks
NEULANDLAB
INE794A01010
Pharmaceuticals
|
Market Closed -
NSE India S.E.
04:35:09 06/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 21,905.00 INR | +0.14% |
|
+2.17% | +44.35% |
| Market Cap | 28TCr 291.36Cr 258.64Cr 242.04Cr 219.38Cr 414.32Cr 417.32Cr 2.91TCr 1.13TCr 14TCr 1.09TCr 1.07TCr 46TCr | P/E 2027 * |
58.7x | P/E 2028 * | 45x |
|---|---|---|---|---|---|
| Enterprise Value | 28TCr 294.02Cr 261Cr 244.25Cr 221.38Cr 418.1Cr 421.12Cr 2.93TCr 1.14TCr 14TCr 1.1TCr 1.08TCr 46TCr | EV / Sales 2027 * |
11.6x | EV / Sales 2028 * | 9.66x |
| Free-Float |
62.26% | Yield 2027 * |
0.11% | Yield 2028 * | 0.14% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| NEULANDLAB | Delayed | |
NSE India S.E.
| NEULANDLAB | Delayed |
Last Transcript: Neuland Laboratories Limited
| 1 day | +0.14% | ||
| 1 week | +2.17% | ||
| Current month | +2.60% | ||
| 1 month | -3.33% | ||
| 3 months | +15.63% | ||
| 6 months | +76.18% | ||
| Current year | +44.35% |
| 1 week | 20,715 |  | 21,975 |
| 1 month | 20,715 | | 24,225 |
| Current year | 11,500 | | 24,225 |
| 1 year | 11,500 | | 24,225 |
| 3 years | 3,611.1 | | 24,225 |
| 5 years | 967 | | 24,225 |
| 10 years | 245.75 | | 24,225 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 47 | 01/04/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 01/01/2002 | |
| Chairman | 82 | 07/01/1984 | |
| Director/Board Member | 47 | 01/03/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | +2.17% | - | - | 291.18Cr | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,01900Cr | |
| +0.73% | -4.78% | +35.41% | +61.62% | 61TCr | |
| +0.35% | +1.29% | +15.86% | +79.90% | 47TCr | |
| +1.72% | -4.92% | +59.84% | +36.64% | 34TCr | |
| +0.26% | -1.58% | +21.97% | +41.79% | 34TCr | |
| +0.60% | -3.48% | +11.37% | +34.33% | 27TCr | |
| +1.65% | -4.27% | -5.47% | +9.69% | 24TCr | |
| -0.09% | -4.97% | +36.88% | +50.52% | 22TCr | |
| -0.28% | -4.66% | +26.99% | +92.98% | 18TCr | |
| Average | +0.35% | -3.71% | +26.65% | +56.92% | 40.92TCr | |
| Weighted average by Cap. | +0.05% | -3.43% | +29.67% | +67.25% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2.44TCr 25Cr 22Cr 21Cr 19Cr 36Cr 36Cr 252.08Cr 98Cr 1.24TCr 95Cr 93Cr 3.99TCr | 2.92TCr 30Cr 27Cr 25Cr 23Cr 43Cr 43Cr 302.04Cr 117.47Cr 1.49TCr 113.63Cr 111.19Cr 4.79TCr |
| Net income | 479.83Cr 4.98Cr 4.42Cr 4.13Cr 3.75Cr 7.08Cr 7.13Cr 50Cr 19Cr 244.78Cr 19Cr 18Cr 786.92Cr | 626.47Cr 6.5Cr 5.77Cr 5.4Cr 4.89Cr 9.24Cr 9.31Cr 65Cr 25Cr 319.59Cr 24Cr 24Cr 1.03TCr |
| Net Debt | 256.12Cr 2.66Cr 2.36Cr 2.21Cr 2Cr 3.78Cr 3.81Cr 27Cr 10Cr 130.66Cr 9.97Cr 9.76Cr 420.03Cr | 98Cr 1.02Cr 90.19L 84.4L 76.5L 1.44Cr 1.46Cr 10Cr 3.94Cr 50Cr 3.81Cr 3.73Cr 160.61Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | ₹21,905.00 | +0.14% | 61,813 |
| 05/26/05 | ₹21,875.00 | +1.72% | 62,813 |
| 01/26/01 | ₹21,505.00 | +0.73% | 70,377 |
| 30/26/30 | ₹21,350.00 | -0.12% | 51,295 |
| 29/26/29 | ₹21,375.00 | -0.30% | 83,910 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions
